SVETLANA MOHEYDEEN: Open Payments
NPI 1265778294 · GROTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$331 in 14 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $331
Food & beverage: $331
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $78 |
| Amgen Inc. | 3 | $55 |
| UCB, Inc. | 1 | $37 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| PFIZER INC. | 1 | $28 |
| ABBVIE INC. | 1 | $23 |
| Sandoz Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Radius Health, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: FARXIGA, Bimzelx, BENLYSTA, PREVNAR 20, UBRELVY, HYRIMOZ, M-M-R II, Tymlos.
Industry payments across MA — which companies pay providers there.
